Emerging pharmacological therapies for ARDS: COVID-19 and beyond
Sign Up to like & getrecommendations! Published in 2020 at "Intensive Care Medicine"
DOI: 10.1007/s00134-020-06141-z
Abstract: ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory failure. Despite considerable advances in our knowledge regarding the pathophysiology of ARDS, insights into the biologic mechanisms of lung injury and… read more here.
Keywords: medicine; pharmacological therapies; ards covid; therapies ards ... See more keywords
Evidence-Based Non-Pharmacological Therapies for Fibromyalgia
Sign Up to like & getrecommendations! Published in 2018 at "Current Pain and Headache Reports"
DOI: 10.1007/s11916-018-0688-2
Abstract: Purpose of ReviewFibromyalgia (FM) is the second most common rheumatologic pain disorder after osteoarthritis with a multisystem presentation. While the treatment of FM in a clinical setting incorporates both pharmacologic and non-pharmacologic modalities, the present… read more here.
Keywords: based non; pharmacological therapies; evidence; evidence based ... See more keywords
Translation from animal studies of novel pharmacological therapies to clinical trials in cardiac arrest: A systematic review.
Sign Up to like & getrecommendations! Published in 2020 at "Resuscitation"
DOI: 10.1016/j.resuscitation.2020.10.028
Abstract: BACKGROUND There is a lack of new promising therapies to improve the dismal outcomes from cardiac arrest. The objectives of this study were: (1) To identify novel pharmacological therapies investigated in experimental animal studies and… read more here.
Keywords: experimental animal; animal studies; novel pharmacological; cardiac arrest ... See more keywords
Pharmacological therapies for pain in Parkinson’s disease – a review paper
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2017.1385393
Abstract: ABSTRACT Introduction: Parkinson’s disease (PD) is a neurodegenerative movement disorder characterized by the loss of dopamine containing cells in the substantia nigra, with pain being one of the most common, yet frequently misunderstood symptoms. The… read more here.
Keywords: therapies pain; pain; review; parkinson disease ... See more keywords
Pharmacological Therapies for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Gastroenterology"
DOI: 10.1097/mcg.0000000000000913
Abstract: Background: Hepatorenal syndrome (HRS) is a serious complication of advanced chronic liver disease. Different pharmacological therapies have variable efficacy. We performed a systematic review and meta-analysis to compare the efficacy of various drugs in the… read more here.
Keywords: plus albumin; analysis; systematic review; hrs ... See more keywords
Non‐pharmacological therapies for pain management in Parkinson's disease: A systematic review
Sign Up to like & getrecommendations! Published in 2021 at "Acta Neurologica Scandinavica"
DOI: 10.1111/ane.13435
Abstract: Among the various non‐motor symptoms of Parkinson's disease (PD), pain is often cited as the most common and debilitating feature. Currently, the literature contains gaps in knowledge with respect to the various forms of treatment… read more here.
Keywords: stimulation; pain management; pain; pharmacological therapies ... See more keywords
Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Pharmacology"
DOI: 10.1111/bph.13721
Abstract: Pulmonary hypertension (PH) is defined by elevated mean pulmonary artery pressure following the pathological remodelling of small pulmonary arteries. An increase in right ventricular (RV) afterload results in RV hypertrophy and RV failure. The pathophysiology… read more here.
Keywords: therapies protect; pulmonary hypertension; novel putative; putative pharmacological ... See more keywords
Chronic Liver Diseases: From Development to Novel Pharmacological Therapies.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of pharmacology"
DOI: 10.1111/bph.15853
Abstract: Chronic liver diseases comprises a broad spectrum of burdensome diseases that still lack effective pharmacological therapies. Our research group focuses on fibrosis, which is a major precursor of liver cirrhosis. Fibrosis consists in a progressive… read more here.
Keywords: liver; development; liver diseases; pharmacological therapies ... See more keywords
5 Non-alcoholic fatty liver disease (NAFLD) -underdiagnosed but overtreated
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Evidence-Based Medicine"
DOI: 10.1136/bmjebm-2019-pod.111
Abstract: NAFLD is the hepatic manifestation of the metabolic syndrome. It is a major cause of hepatic morbidity and mortality worldwide, and in addition there is significant morbidity and mortlaity due to the complications of obesity… read more here.
Keywords: alcoholic fatty; fatty liver; non alcoholic; disease ... See more keywords
Non-pharmacological therapies for the treatment of post-traumatic stress disorder among emergency responders: a scoping review.
Sign Up to like & getrecommendations! Published in 2021 at "Revista da Escola de Enfermagem da U S P"
DOI: 10.1590/s1980-220x2020011603724
Abstract: OBJECTIVE Identify non-pharmacological therapies for the treatment of post-traumatic stress disorder in emergency responders. METHOD Scope review according to the guidelines of the Joanna Briggs Institute and the PRISMA-ScR protocol. A search was conducted in… read more here.
Keywords: therapy; non pharmacological; treatment; pharmacological therapies ... See more keywords
Comparative efficacy of 5 non-pharmacological therapies for adults with post-stroke cognitive impairment: A Bayesian network analysis based on 55 randomized controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.977518
Abstract: Background As a common sequela after stroke, cognitive impairment negatively impacts patients' activities of daily living and overall rehabilitation. Non-pharmacological therapies have recently drawn widespread attention for their potential in improving cognitive function. However, the… read more here.
Keywords: controlled trials; stroke cognitive; non pharmacological; cognitive impairment ... See more keywords